Literature DB >> 22949454

Posing a framework to guide government's role in payment and delivery system reform.

Neeraj Sood1, Aparna Higgins.   

Abstract

Innovative payment reform initiatives occur in both the public and private sector, but the optimal role in such reforms of the public sector, specifically the Centers for Medicare and Medicaid Services, is up for debate. In this article we examine recent experiences with public-private collaboration on payment and delivery reform and present a framework for determining the role of the government in spurring reform. We argue that as a purchaser, the government should consider the scale and maturity of private-sector activity in determining how to approach designing and implementing payment and delivery system reform. The government can further spur innovation by implementing payment reform for providers less ready to participate in it-such as smaller provider groups with limited organizational and technological capacity to implement reform-through identifying best practices related to attribution models and quality benchmarks and promoting dialogue with the private sector about the testing of new reform programs.

Mesh:

Year:  2012        PMID: 22949454     DOI: 10.1377/hlthaff.2012.0382

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

1.  Strengthening Multipayer Collaboration: Lessons From the Comprehensive Primary Care Initiative.

Authors:  Grace Anglin; H A Tu; Kristie Liao; Laura Sessums; Erin Fries Taylor
Journal:  Milbank Q       Date:  2017-09       Impact factor: 4.911

2.  The Effects of Accountable Care Organizations Forming Preferred Skilled Nursing Facility Networks on Market Share, Patient Composition, and Outcomes.

Authors:  Jing Gu; Peter Huckfeldt; Neeraj Sood
Journal:  Med Care       Date:  2021-04-01       Impact factor: 3.178

3.  Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions.

Authors:  Jing Gu; Neeraj Sood; Abe Dunn; John Romley
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.